Strongyloides hyperinfection in Ethiopian immigrants in Israel

Israel Medical Association Journal

Volumn 11, Issue 11, 2009, Pages 660-663

  Malnick, Stephen ^a   Somin, Marina ^a   Beilinson, Nick ^a   Basevitch, Alon ^a   Bregman, Gennady ^b   Zimhony, Oren ^a,c  

^a KAPLAN MEDICAL CENTER   (Israel)

^b Intensive Care Unit   (Israel)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

Immigrants; Immunosuppression; Meningitis; Strongyloides stercoralis

Indexed keywords

ALKALINE PHOSPHATASE; AMPICILLIN; ASPARTATE AMINOTRANSFERASE; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; DEXAMETHASONE; EFAVIRENZ; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; IMMUNOGLOBULIN E; IVERMECTIN; LAMIVUDINE; METHYLPREDNISOLONE; PIPERACILLIN; TENOFOVIR; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; CACHEXIA; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCAL MENINGITIS; DIARRHEA; DRUG DOSE REDUCTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DUODENUM ULCER; DYSPNEA; EOSINOPHILIA; ERYTHROCYTE TRANSFUSION; ESOPHAGOGASTRODUODENOSCOPY; FATALITY; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; HYPOTHERMIA; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; NAUSEA; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; ODYNOPHAGIA; PNEUMOCYSTIS PNEUMONIA; PROTEIN BLOOD LEVEL; PSEUDOMONAS INFECTION; RELAPSE; RIGIDITY; SEPSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TACHYPNEA; THROMBOCYTE COUNT; TREATMENT REFUSAL; TREATMENT RESPONSE; VOMITING; WHEEZING;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED, 80 AND OVER; ANIMALS; EMIGRANTS AND IMMIGRANTS; ETHIOPIA; FEMALE; HUMANS; ISRAEL; MALE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION;

EID: 73449143198     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunosuppressed population. Clin Microb Rev 2004; 17: 208-17.
2. Walzer PD, Milder JE, Banwell JG, Kilgore G, Klein M, Parker R. Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg 1982; 31: 313-19.
3. Posey DL, Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis 2007; 45: 1310-15.
4. Boulware DR, Stauffer WM, Hendel-Paterson BR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med 2007; 120: 545-51.
5. De Oliveira LC, Ribeiro LT, Mendes Dole M, Oliveira TC, Costa-Cruz JM. Frequency of Strongyloides stercoralis infection in alcoholics. Mem Inst Oswaldo Cruz 2002; 97: 119-21.
6. Davidson RA, Fletcher RH, Chapman LE. Risk factors for strongyloidiasis. A case-control study. Arch Intern Med 1984; 144: 321-4.
7. Husni RN, Gordon SM, Longworth DL, Adal KA. Disseminated Strongyloides stercoralis infection in an immunocompetent patient. Clin Infect Dis 1996; 23: 663.
8. Somin M, Neogolani V, Zimhony O, Wolpart A, Sokolowski N, Malnick 8. k S. Fatal recurrent bacterial meningitis: a complication of chronic Strongyloides infection. Eur J Intern Med. 2008; 6: 42-3.
9. Smith B, Verghese A, Guiterrez C, Bralle W, Berk SL. Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. Am J Med 1985; 79: 663-6.
10. Warts R, Mirot M, Fronda G, Peters C, Kocka F.; gastric infection by Strongyloides stercoralis. Am J Trop Med Hyg 1994; 51: 339-40.
11. West BC, Wilson JP. Subconjunctival corticosteroid therapy complicated by hyperinfective strongyloidiasis. Am J Opthalmol 1980; 89: 851-7.
12. Cummins RO, Swatt PM, Horwitz DA. Disseminated Strongyloides stercoralis infection. Association with ectopic adrenocorticotropin syndrome and depressed cell-medicated immunity. Arch Intern Med 1978; 138: 1005-6.
13. Debussche X, Toublanc M, Camillieri JP, Asyan R. Overwhelming Strongyloides in a diabetic patient following adrenocorticotrophin treatment and ketoacidosis. Diabetes Metab 1988; 14: 294-8.
14. Pelletier LL. Chronic strongyloidiasis in World War II Far East ex-prisoners of war. Am J Trop Med Hyg 1984; 33: 55-61.
15. Nahmias J, Greenberg Z, Djerassi L, Giladi L. Mass treatment of intestinal parasites among Ethiopian immigrants. Isr J Med Sci 1991; 27: 278-83.
16. Viney ME, Brown M, Omoding NE, et al. Why does HIV infection not lead to disseminated strongyloidiasis. J Infect Dis. 2004; 190: 2175-80.
17. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002; 66: 749-52.
18. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995; 53: 248-50.
19. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33: 1040-7.
20. Goka AK, Rolston DD, Mathan VI, Farthing MJ. Diagnosis of Strongyloides and hookworm infections: comparison of faecal and duodenal fluid microscopy. Trans R Soc Trop Med Hyg 1990; 84: 829-31.
21. Genta RM. Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988; 89: 391-4.
22. Rosenberg R, Vinker S, Zakut H, Kizner F, Nakar S, Kitai E. An unusually high prevalence of asthma in Ethiopian immigrants to Israel. Fam Med 1999; 31: 276-9.
23. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, Takara M. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health. 2000; 1: 147-51.
24. Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect 2004; 132: 1055-63.